Karolinska Institutet, Department of Medicine Solna, Unit of Immunology and Allergy, Stockholm, Sweden.
Department of Urology, Sundsvall Hospital, Sundsvall, Sweden.
Clin Exp Immunol. 2018 Oct;194(1):39-53. doi: 10.1111/cei.13183. Epub 2018 Aug 24.
Tissue-resident memory T (T ) cells are CD8 T lymphocytes that reside in the tissues, including tumours. This T cell subset possesses a magnitude of cytotoxicity, but its epigenetic regulation has not been studied. Here, we investigate the impact of perforin DNA methylation in T cells and correlate it with their functional potential. Fifty-three urothelial urinary bladder cancer (UBC) patients were recruited prospectively. The DNA methylation status of the perforin gene (PRF1) locus in T cells was investigated by pyrosequencing. Flow cytometry with ViSNE analysis and in-vitro stimulation were used to evaluate T cell phenotypes. We discovered that tumour T cells have low DNA methylation in the PRF1 locus (32·9% methylation), which corresponds to increased numbers of perforin-expressing T cells. Surprisingly, programmed cell death 1 (PD-1) expression is high in tumour T cells, suggesting exhaustion. Following interleukin-15 and T cell receptor stimulation, perforin and T-bet expressions are enhanced, indicating that T cells from tumours are not terminally exhausted. Moreover, a high number of T cells infiltrating the tumours corresponds to lower tumour stage in patients. In conclusion, T cells from UBC tumours are epigenetically cytotoxic with signs of exhaustion. This finding identifies T cells as potential new targets for cancer immunotherapy.
组织驻留记忆 T(T)细胞是存在于组织中的 CD8 T 淋巴细胞,包括肿瘤。这种 T 细胞亚群具有一定的细胞毒性,但它的表观遗传调控尚未得到研究。在这里,我们研究了穿孔素 DNA 甲基化对 T 细胞的影响,并将其与它们的功能潜力相关联。我们前瞻性地招募了 53 名尿路上皮膀胱癌(UBC)患者。通过焦磷酸测序研究 T 细胞中穿孔素基因(PRF1)基因座的 DNA 甲基化状态。通过流式细胞术 ViSNE 分析和体外刺激来评估 T 细胞表型。我们发现肿瘤 T 细胞中 PRF1 基因座的 DNA 甲基化程度较低(32.9%的甲基化),这对应于表达穿孔素的 T 细胞数量增加。令人惊讶的是,肿瘤 T 细胞中程序性细胞死亡 1(PD-1)的表达水平较高,表明衰竭。在白细胞介素 15 和 T 细胞受体刺激后,穿孔素和 T 细胞转录因子表达增强,表明肿瘤中的 T 细胞并未终末衰竭。此外,浸润肿瘤的大量 T 细胞与患者的肿瘤分期较低相对应。总之,UBC 肿瘤中的 T 细胞具有表观遗传细胞毒性,并表现出衰竭的迹象。这一发现将 T 细胞确定为癌症免疫治疗的潜在新靶点。